COVID-19: Synthetic antibodies reduce hospitalizations and deaths

The combination of two synthetic antibodies from the US pharmaceutical group Eli Lilly against COVID-19 has reduced hospitalizations and deaths by 70% in high-risk patients who recently tested positive for …

Read more